(Total Views: 745)
Posted On: 04/29/2020 7:16:32 PM
Post# of 148936
"Under the agreement between Gilead and U.S. Army Medical Materiel Development Activity, remdesivir will be provided to the Defense Department at no cost."
https://www.militarytimes.com/news/your-milit...treatment/
That article popped up a few days after CytoDyn's conference call with these 2 items on top of the list for discussion.
Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and advisor to CytoDyn, will provide a detailed explanation of the mechanism of action for treating coronavirus with leronlimab
Filing of an IND and Phase 2 clinical trial protocol with the FDA for the treatment of coronavirus with leronlimab in the U.S.
Maybe Gilead knew it was screwed if it didn't start throwing favors.
https://www.militarytimes.com/news/your-milit...treatment/
That article popped up a few days after CytoDyn's conference call with these 2 items on top of the list for discussion.
Bruce Patterson, M.D., chief executive officer and founder of IncellDx, a diagnostic partner and advisor to CytoDyn, will provide a detailed explanation of the mechanism of action for treating coronavirus with leronlimab
Filing of an IND and Phase 2 clinical trial protocol with the FDA for the treatment of coronavirus with leronlimab in the U.S.
Maybe Gilead knew it was screwed if it didn't start throwing favors.
(1)
(0)Scroll down for more posts ▼
